Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia

National Cancer Institute (NCI) · 2007
ClinicalTrials.gov · Datasets · License: Public Domain · 2007
Open Source ↗
q12
acute undifferentiated leukemia, adult acute myeloid leukemia with 11q23 (mll) abnormalities, adult acute myeloid leukemia with inv(16)(p13;q22), adult acute myeloid leukemia with t(15;17)(q22;q12), adult acute myeloid leukemia with t(16;16)(p13;q22), adult acute myeloid leukemia with t(8;21)(q22;q22), blastic phase chronic myelogenous leukemia, de novo myelodysplastic syndromes, previously treated myelodysplastic syndromes, recurrent adult acute lymphoblastic leukemia, recurrent adult acute myeloid leukemia, relapsing chronic myelogenous leukemia
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 1032636
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.